Kera Capital Partners’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Kera Capital Partners's PHAT Position: Q3 2026 in Review
Kera Capital Partners increased its Phathom Pharmaceuticals (PHAT) stake by 0.01% in Q3 2026, buying an estimated $38 and bringing the position to 26,830 shares worth $196K. The position accounts for 0.02% of the portfolio, ranked #671.
Kera Capital Partners first reported a position in PHAT in Q4 2024 and has held it in 8 quarters since. The position peaked at $354K in Q3 2025. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Kera Capital Partners held 26,830 shares of Phathom Pharmaceuticals worth $196K as of Q3 2026.
- Kera Capital Partners bought 4 Phathom Pharmaceuticals shares in Q3 2026, an estimated $38.
- Phathom Pharmaceuticals made up 0.02% of Kera Capital Partners's portfolio in Q3 2026, its #671 holding.
- Kera Capital Partners first reported a position in Phathom Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- Kera Capital Partners's Phathom Pharmaceuticals position peaked at $354K in Q3 2025.
- 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Kera Capital Partners's 13F filing for Q3 2026, filed 13 Nov 2026.